发明名称 BACTERIAL THIOREDOXIN REDUCTASE INHIBITORS AND METHODS FOR USE THEREOF
摘要 The mechanism of action of Ebselen differentiates between bacterial and mammalian thioredoxin reductase (TrxR). It displays fast oxidation of mammalian Trx and via the NADPH-TrxR catalyzed turnover of ebselen selenol with hydrogen peroxide, and therefore are mammalian antioxidants. Ebselen, and its diselenide, are strong competitive inhibitors of E.coli TrxR with Ki of 0.14 µM and 0.46 µM, respectively. E.coli mutants lacking glutathione reductase or glutathione were much more sensitive to inhibition by ebselen. Since either glutaredoxin or thioredoxin systems are electron donors to ribonucleotide reductase, ebselen targets primarily glutathione and glutaredoxin-negative bacteria, a class which includes major pathogens. Ebselen, and similar compounds are therefore useful as antibacterial agents, even for multiresistant strains. Two major pathogenic bacteria, which previously had not been known to be sensitive to ebselen, Mycobacterium tuberculosis (tuberculosis) and Helicobacter pylori (stomach ulcer and cancer), were shown to be excellent targets. Helicobacter
申请公布号 WO2007137255(A3) 申请公布日期 2008.12.11
申请号 WO2007US69455 申请日期 2007.05.22
申请人 THIOREDOXIN SYSTEMS AB;THYOGEN PHARMACEUTICALS, INC.;HOLMGREN, ARNE;LU, JUN;VLAMIS-GARDIKAS, ALEXIOS;ZHAO, RONG;KANDASAMY, K.;ENGMAN, LARS;ENGSTRAND, LARS;HOFFNER, SVEN 发明人 HOLMGREN, ARNE;LU, JUN;VLAMIS-GARDIKAS, ALEXIOS;ZHAO, RONG;KANDASAMY, K.;ENGMAN, LARS;ENGSTRAND, LARS;HOFFNER, SVEN
分类号 A61K31/555;A61K31/38;A61K31/385 主分类号 A61K31/555
代理机构 代理人
主权项
地址